Antegenes is an innovation-oriented Estonian health technology company founded in 2018. Antegenes is a healthcare provider of medical genetics, oncology and laboratory services registered by the Estonian Health Board. All our tests are registered as CE-marked medical devices (in vitro diagnostics, IVD). Our quality management system complies with the ISO 13485:2016 standard.
We have developed novel polygenic risk score based genetic tests to estimate the risk of common cancers. The polygenic risk score sums up information over hundreds to thousands of genetic variants in the human genome. By combining the polygenic risk score with a person’s background (origin, age, and gender), we can calculate a person’s risk of developing cancer and provide medical advice on prevention and early detection.
Our mission is to enable people to have a better, healthier, and longer life by helping individuals, healthcare professionals, and organizations use genetic information for personal and public health.
